Literature DB >> 21833022

Genetic diversity in human erythrocyte pyruvate kinase.

J Berghout1, S Higgins, C Loucoubar, A Sakuntabhai, K C Kain, P Gros.   

Abstract

Previously, we have shown that pyruvate kinase, liver and red cell isoform (PKLR) deficiency protects mice in vivo against blood-stage malaria, and observed that reduced PKLR function protects human erythrocytes against Plasmodium falciparum replication ex vivo. Here, we have sequenced the human PKLR gene in 387 individuals from malaria-endemic and other regions in order to assess genetic variability in different geographical regions and ethnic groups. Rich genetic diversity was detected in PKLR, including 59 single-nucleotide polymorphisms and several loss-of-function variants (frequency 1.5%). Haplotype distribution and allele frequency varied considerably with geography. Neutrality testing suggested positive selection of the genein the sub-Saharan African and Pakistan populations. It is possible that such positive selection involves the malarial parasite.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833022     DOI: 10.1038/gene.2011.54

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  8 in total

1.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

2.  Identification of biochemically neutral positions in liver pyruvate kinase.

Authors:  Tyler A Martin; Tiffany Wu; Qingling Tang; Larissa L Dougherty; Daniel J Parente; Liskin Swint-Kruse; Aron W Fenton
Journal:  Proteins       Date:  2020-06-27

3.  Prevalence of pyruvate kinase deficiency: A systematic literature review.

Authors:  Matthew H Secrest; Mike Storm; Courtney Carrington; Deborah Casso; Keely Gilroy; Leanne Pladson; Audra N Boscoe
Journal:  Eur J Haematol       Date:  2020-06-23       Impact factor: 2.997

4.  A novel homozygous missense variant p.D339N in the PKLR gene correlates with pyruvate kinase deficiency in a Pakistani family: a case report.

Authors:  Atta Ur Rehman; Abdur Rashid; Zubair Hussain; Khadim Shah
Journal:  J Med Case Rep       Date:  2022-02-16

5.  Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro.

Authors:  Inês Morais; Márcia M Medeiros; Maria Carvalho; Judit Morello; Sara M Teixeira; Suelma Maciel; Janice Nhantumbo; Ana Balau; Margarida T G Rosa; Fátima Nogueira; João Alexandre Rodrigues; Filomena A Carvalho; Alexandra M M Antunes; Ana Paula Arez
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

6.  The host genetic diversity in malaria infection.

Authors:  Vitor R R de Mendonça; Marilda Souza Goncalves; Manoel Barral-Netto
Journal:  J Trop Med       Date:  2012-12-13

7.  Pyruvate kinase deficiency in sub-Saharan Africa: identification of a highly frequent missense mutation (G829A;Glu277Lys) and association with malaria.

Authors:  Patrícia Machado; Licínio Manco; Cláudia Gomes; Cristina Mendes; Natércia Fernandes; Graça Salomé; Luis Sitoe; Sérgio Chibute; José Langa; Letícia Ribeiro; Juliana Miranda; Jorge Cano; João Pinto; António Amorim; Virgílio E do Rosário; Ana Paula Arez
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

8.  Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.

Authors:  Rebekah van Bruggen; Christian Gualtieri; Alexandra Iliescu; Chalisa Louicharoen Cheepsunthorn; Punchalee Mungkalasut; Jean-François Trape; David Modiano; Bienvenu Sodiomon Sirima; Pratap Singhasivanon; Mark Lathrop; Anavaj Sakuntabhai; Jean-François Bureau; Philippe Gros
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.